Negar Shahkarami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Negar Shahkarami has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad-Rafi Bazrafshan
Department of Nursing, School of Nursing, Larestan University of Medical Sciences, Larestan, Iran
2 shared publications - Amir Mansouri
Department of Paramedical School, Gerash University of Medical Sciences, Gerash, Iran
1 shared publication - Atena Samareh Fekri
Department of Anesthesiology, Faculty of Allied Medical Sciences, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication - Elahe Zaremoghadam
Department of Internal Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran
1 shared publication - Esmaeil Kavi
Larestan University of Medical Sciences
1 shared publication - Fatemeh Zare
Student Research Committee, Larestan University of Medical Sciences, Larestan, Iran
1 shared publication
Latest Publications
- 30 June 2025
- Published by Taylor & Francis in Journal of Substance Use
- Vol. 31 (2) , 285-291
The relationship between midwakh use and depression: a comprehensive narrative review
- 30 June 2025
- Published by Taylor & Francis in Journal of Substance Use
- Vol. 31 (2) , 285-291
The relationship between midwakh use and depression: a comprehensive narrative review
- 18 June 2025
- Published by Maad Rayan Publishing Company in Journal of Multidisciplinary Care
- Vol. 13 (2) , 55-61
Challenges of families in caring for a patient with COVID-19 during the home quarantine period: A qualitative study
Background and aims: The significant spread of COVID-19 in Iran and the increasing number of cases and deaths caused by this deadly disease have faced the healthcare system with one of the biggest health challenges in the last decade. In such a situation, the role of families in dealing with challenges is inevitable. The present study was designed to explain the challenges faced by families in caring for a patient with COVID-19 during the home quarantine period. Methods: In this qualitative design, data were collected from 38 family members of patients with COVID-19 who took care of their patients at home by using semi-structured interviews in Lar, Evaz, and Gerash between December 2021 and March 2022. The participants in the study were chosen using purposive and snowball sampling methods. The interviews were recorded and transcribed word-for-word in Persian. The content analysis approach of Graneheim and Lundman (2004) was used to analyze the data. Results: This study’s participants were 38 people, the average age of whom was 42.79±12.796 years. After analyzing the data, five main categories of personal factors, social factors, economic factors, environmental factors, and physical and physiological factors with 28 subgroups were extracted. Conclusion: The results showed that families caring for patients with COVID-19 have faced many challenges. Based on this, social, economic, psychological, and educational measures and support can greatly reduce these challenges.
- 18 June 2025
- Published by Maad Rayan Publishing Company in Journal of Multidisciplinary Care
- Vol. 13 (2) , 55-61
Challenges of families in caring for a patient with COVID-19 during the home quarantine period: A qualitative study
Background and aims: The significant spread of COVID-19 in Iran and the increasing number of cases and deaths caused by this deadly disease have faced the healthcare system with one of the biggest health challenges in the last decade. In such a situation, the role of families in dealing with challenges is inevitable. The present study was designed to explain the challenges faced by families in caring for a patient with COVID-19 during the home quarantine period. Methods: In this qualitative design, data were collected from 38 family members of patients with COVID-19 who took care of their patients at home by using semi-structured interviews in Lar, Evaz, and Gerash between December 2021 and March 2022. The participants in the study were chosen using purposive and snowball sampling methods. The interviews were recorded and transcribed word-for-word in Persian. The content analysis approach of Graneheim and Lundman (2004) was used to analyze the data. Results: This study’s participants were 38 people, the average age of whom was 42.79±12.796 years. After analyzing the data, five main categories of personal factors, social factors, economic factors, environmental factors, and physical and physiological factors with 28 subgroups were extracted. Conclusion: The results showed that families caring for patients with COVID-19 have faced many challenges. Based on this, social, economic, psychological, and educational measures and support can greatly reduce these challenges.
- Open Access
- 1 January 2023
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e25120
Biomarkers in IgA nephropathy; an update to recent data
Biomarkers are molecules that can be measured in the body and can reflect disease activity or progression. They can be used to diagnose and monitor disease, predict treatment response, and identify potential therapeutic targets. Several types of biomarkers have been studied in the context of IgA nephropathy, including protein, gene expression, epigenetic, and microRNA biomarkers. Biomarkers have the potential to improve the accuracy and specificity of the diagnosis of IgA nephropathy and predict the disease progression and response to treatment. However, further studies are needed to validate their diagnostic value in larger cohorts of patients and to integrate them into clinical practice. The development of multi-omics approaches that combine different types of biomarkers may provide a more comprehensive understanding of the disease pathogenesis and potential treatments.
- 1 January 2023
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e25120
Open AccessBiomarkers in IgA nephropathy; an update to recent data
Biomarkers are molecules that can be measured in the body and can reflect disease activity or progression. They can be used to diagnose and monitor disease, predict treatment response, and identify potential therapeutic targets. Several types of biomarkers have been studied in the context of IgA nephropathy, including protein, gene expression, epigenetic, and microRNA biomarkers. Biomarkers have the potential to improve the accuracy and specificity of the diagnosis of IgA nephropathy and predict the disease progression and response to treatment. However, further studies are needed to validate their diagnostic value in larger cohorts of patients and to integrate them into clinical practice. The development of multi-omics approaches that combine different types of biomarkers may provide a more comprehensive understanding of the disease pathogenesis and potential treatments.